| scholarly article | Q13442814 |
| P2093 | author name string | Jenn-Huei Renn | |
| Hua-Chang Fang | |||
| Kang-Ju Chou | |||
| Po-Tsang Lee | |||
| Nai-Ching Chen | |||
| Chien-Liang Chen | |||
| Chih-Yang Hsu | |||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | renal dialysis | Q202301 |
| hyperparathyroidism | Q1344835 | ||
| P304 | page(s) | 2426-2432 | |
| P577 | publication date | 2014-03-26 | |
| P1433 | published in | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
| P1476 | title | An open-label, prospective pilot clinical study of denosumab for severe hyperparathyroidism in patients with low bone mass undergoing dialysis | |
| P478 | volume | 99 |
| Q37639872 | Chronic kidney disease and fragility fracture |
| Q41622523 | Denosumab for Male Hemodialysis Patients with Low Bone Mineral Density: A Case-Control Study |
| Q59806661 | Denosumab-Induced Severe Hypocalcaemia in Chronic Kidney Disease |
| Q93059879 | Evaluation of the association of Wnt signaling with coronary artery calcification in patients on dialysis with severe secondary hyperparathyroidism |
| Q88527655 | Hypocalcemia and bone mineral density changes following denosumab treatment in end-stage renal disease patients: a meta-analysis of observational studies |
| Q87900128 | Management of Osteoporosis in CKD |
| Q39328170 | Positioning novel biologicals in CKD-mineral and bone disorders. |
| Q59126536 | Rethinking Bone Disease in Kidney Disease |
| Q37670856 | The Strategy to Prevent and Regress the Vascular Calcification in Dialysis Patients. |
| Q50223566 | Unusual cause of hypercalcaemia in end stage renal failure patients |
| Q57796694 | Updates in CKD-Associated Osteoporosis |
Search more.